Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Phosphate mixture refers to a combination of inorganic phosphate salts, most commonly potassium phosphate and sodium phosphate, used as a mineral and electrolyte supplement. These mixtures are typically administered orally or intravenously to treat or prevent hypophosphatemia (low blood phosphorus levels), acidify urine to prevent certain types of kidney stones, and sometimes as part of bowel preparation regimens before medical procedures. The mechanism of action involves providing bioavailable phosphorus for cellular processes (including bone formation, energy metabolism, and nucleic acid synthesis) or altering urinary pH. In the context of kidney stone prevention, increasing urinary acidity helps reduce calcium stone formation[3][6][8][10].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on phosphate mixture.